Belgian Monitoring Centre for
Drugs and Drug Addiction
datum : 29/07/2017
uw ref. :
onze ref. :
bijlage(n) :
contact : WIV-ISP
tel. : + 32 2 642 50 34
fax : + 32 2 642 50 01
e-mail : [email protected]
Agenda 2011.04.13. meeting of heads of focal points in Belgium
1. BMCDDA acknowledgement: structural changes and staff changes at the BMCDDA
2. BMCDDA acknowledgement: complaint by EUROTOX and planned consultation by
EMCDDA and Belgian representatives in EMCDDA management board
3. BMCDDA proposition: content of subcontracts 2011 between BMCDDA and VAD,
EUROTOX, SPZ
4. BMCDDA proposition: organisation of formal work groups on EMCDDA key projects
5. BMCDDA proposition: development of new BIRN-information system
6. BMCDDA proposition: change in work method of Belgian Annual Report 2011
7. BMCDDA proposition: collaborative organisation of national REITOX academy in 2012
8. BMCDDA position: financing of toxicological analyses
9. Varia
Juliette Wytsmanstraat 14
1050 Brussel | België
T + 32 2 642 51 11 | F + 32 2 642 50 01
[email protected] | www.wiv-isp.be
1. BMCDDA acknowledgement: structural changes and staff changes at the BMCDDA
1.1.
Structural changes
Previously all activities were centralised without differentiation into “Drugs and Illegal
Substances Program”.
2011: differentiation between research program on substance use and the national focal
point. Within the Department Surveys, Lifestyle and Chronic Diseases of the Operational
Directory Public Health and Surveillances, the epidemiological research on substance use
and related disorders is concentrated in the research program “Substance Use and Related
Disorders” (SURD).
This program hosts the national focal point of the REITOX-network, the Belgian Monitoring
Centre for Drugs and Drug Addiction (BMCDDA).
Substance Use and Related Disorders research program (SURD).
onderzoeksprogramma Middelengebruik en Middelgerelateerde Stoornissen (MMS)
Belgian Monitoring Centre for Drugs and Drug Addiction (BMCDDA).
Belgisch Waarnemingscentrum Drugs en Drugsverslaving (BWDD)
Obseratoir Belge de Drogues et Toxicomanie (OBDT)
In our own communication, we prefer the English name and if the Dutch or French name (in
full) is used, the English abbreviation (BMCDDA) is used.
As for the SURD, the scope is broader than what EMCDDA is focussing on, illicit drugs. The
research of the SURD
For example:
Coordination of TDI is BMCDDA.
Chair of CoCoTDI is BMCDDA
TDI-agreement between RIZIV/INAMI and WIV-ISP is SURD.
SURD participates in ADAPTE-Youth project .
SURD is invited to participate in project of unintended use of medication …
SURD provides FOD/SPF analyses on unintended use of medication
1.2.
Staff
Antoine, Jerome, Ir., MSc.
TDI*, EWS
Asueta-Lorente, Juan, Ma
BELSPO, GPS (a.i.),
Bollaerts, Kaatje, MSc, PhD.
*DRD, *DRID, *PDU
Deprez, Nathalie, Ma.
*BAR, *ST/SQ, GPS
van Bussel, Johan, Ma., MSc., PhD.
*HFP, *TDI, DRID, *GPS, EWS
Vanderlinden, Trudy, MSc.
*EWS, DRID
1.3.
Priorities of BMCDDA
a) Belgian Annual Report and Standard Tables / Structured Questionnaires:
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
2
Development and implementation of web-based information management system to
submit data relevant to BAR and ST/SQ.
b) Treatment Demand Indicator:
Development and implementation of technical platform to register or submit TDI data.
Mapping of facilities and description of activities (better interpretation of registered
data)
Development generic feedback system (incl. benchmarking) for treatment units
c) Drug Related Infectious Diseases:
Development and validation of DRID study protocol (in Dutch and French) based on
the new EMCDDA DRID study guidelines (in process)
Baseline serological data on prevalence of HIV, HBV and HCV in IDU’s
d) Early Warning System:
Development and implementation of new technical platform to register or submit EWS
data.
Development generic feedback system (incl. benchmarking) for laboratories, courts
and police districts.
BMCDDA Project proposal: development and implementation of Unique Sample
Identifier and Unique Report used by laboratories, courts and police services.
Establishment of Risk Assessment Group
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
3
1.4.
2. BMCDDA acknowledgement: complaint by EUROTOX and planned
consultation by EMCDDA and Belgian representatives in EMCDDA management
board
2011.03.21. Formal letter of EMCDDA mentioning complaint
2011.02.25. invitation Chapter 3 BAR 2011 to authors
2011.02.28. EUROTOX: complaint at French Community (and later EMCDDA)
2010.10.28. invitation 1 meeting HFP.be
Meeting: 2011.09.30
Alexis Goosdeel, Marijs Geirnaert / Fred Laudens, Lucia Casero,
Invitation Cc.: Claude Gillard, Philippe Demoulin
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
4
3. BMCDDA proposition: content of subcontracts 2011 between BMCDDA and VAD,
EUROTOX, SPZ
3.1. Financial
2011: same value as in 2010 (without indexation)
2012: a) review of “basis of apportionment”; b) expected decrease of available sources
3.2. Tasks
3.2.1. Generic tasks
Task
A. Belgian Annual Report 2011 (BAR2011)
1. Participation meeting evaluation of EMCDDA quality assessment of Belgian
Annual Report
2. Participation development web-based information management system
3. Use of web-based information management system to submit information
for BAR and ST/SQ
4. Writing (in collaboration with RFP) BAR Chapter 3. Prevention
5. Review of BAR2011
B. Standard Tables / Structured Questionnaires
6. Participation meeting evaluation of EMCDDA quality assessment of Belgian
Standard Tables / Structured Questionnaires
7. Submission ST 02 into FONTE: Methodology and results of school surveys
on drug use
8. Submission ST 09-1 into FONTE: Prevalence of hepatitis B/C and HIV
infection among injecting drug users: methods
9. Submission ST 09-2 into FONTE: Prevalence of hepatitis B/C and HIV
infection among injecting drug users
10. Submission ST 09-3 into FONTE: Voluntary results for Behavioural
Surveillance and Protective Factors
11. Submission ST 09-4 into FONTE: Notified cases of hepatitis C and B in
injecting drug users
12. Submission ST 10 into FONTE: Syringe availability
13. Submission ST 17 into FONTE: Leading edge indicators for new
developments in drug consumption
14. Submission ST 23 into FONTE: Harm reduction measures to prevent
infectious diseases
Deadline
TBA
TBA
Ad hoc
01/09/2011
01/10/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
01/08/2011
C. Early Warning System on Drugs
15. Participation meetings (3) optimalisation of dataflow in EWS*
16. Participation meetings (3) optimalisation of a) dissimenation EWS Warnings
and b) EWS Risk Assessment Group*
17. Rapid exchange of EWS information provided by regional EWS network, to
WIV-ISP
18. Rapid exchange of EWS information provided by national EWS, to regional
EWS network
19. Submission of Annual EWS activities report to BMCDDA
Ad hoc
D. Drugs Related Deaths
20. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on Drugs Related Deaths*
TBA
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
TBA
TBA
Ad hoc
TBA
5
E. Drugs Related Infectious Diseases
21. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on Drugs Related Infectious Diseases (DRID)*
F. General Population Survey
22. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on General Population Survey (GPS)*
TBA
G. Problematic Drug Use
23. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on Problematic Drug Use (PDU)*
TBA
H. Treatment Demand Indicator
24. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on Treatment Demand Indicator (TDI)*
TBA
I. Exchange on Drug Demand Reduction Action
25. Participation meeting evaluation of EMCDDA quality assessment of Belgian
activities on Exchange on Drug Demand Reduction Action (EDDRA)*
TBA
J. Network management
26. Participation meetings (4) heads of Focal Points Belgium*
27. Update contact information RFP responsible using SharePoint
Ad hoc
28. Distribution of EMCDDA reports and other products;
Ad hoc
29. Informing relevant partners and network(s) about quality feedback provided Ad hoc
by the EMCDDA and the BMCDDA;
30. Responding to EMCDDA queries dispatched by the BMCDDA
Ad hoc
31. Language checking and proof-reading of EMCDDA products
Ad hoc
32. Technical Activities Report (execution of contract)
TBA
33. Financial Report (execution of contract)
TBA
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
6
4. BMCDDA proposition: organisation of formal work groups on EMCDDA key projects
First step: See Generic tasks subcontracts 2011 between BMCDDA and VAD, EUROTOX,
SPZ: evaluation van de EMCDDA quality assessment regarding Belgian activities
RFP responsables will receive before end of April an invitation from respective BMCDDA
responsables.
Second step: establishment of formal working groups by inviting external experts. Goal:
development of roadmap to increase quality of monitoring and more frequent
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
7
5. BMCDDA proposition: development of (BIRN) web-based information management
system
Objective: collecting information (scientific studies, prevention initiatives, public policy
initiatives, … , in a complete and standardised way to facilitate both the analysis of the
information and the integration of the information into the products BAR and ST/SQ.
Method: development of a website guiding the information provider through the desired
format for the relevant information.
Information providers:
Regional focal points are requested to submit – on a continuously basis information provided by / collected in organisations under competence of regional or
community administration (Schools, Universities, prevention services, treatment
centers conventioned with regional or community administration/authority, mental
health services).
BMCDDA submits information provided by / collected in organisations under
competence of federal administration (Police units, Courts, Public Health services
under federal, including hospitals ).
Output: Database accessible for Regional Focal Points and BMCDDA.
i.c. data provided by police services of hospitals in a certain region, will be available
for regional focal point and BMCDDA.
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
8
6. BMCDDA proposition: change in work method of Belgian Annual Report 2011
Objective: increase quality of Belgian Annual Reports
Methods: Chapters outside the expertise and competence of the BMCDDA, are
subcontracted to experts.
For example: The BMCDDA has no legal expertise, therefore Chapter 1 is subcontracted to
Prof. Dr. Brice De Ruyver and his colleagues. As prevention is a competence of the regions /
communities, we subcontracted Chapter 3 to the Regional Focal Points (as part of the basic
contract with BMCDDA and).
The monthly editorial meetings with the Regional Focal Points are not continued. The
‘BMCDDA’ authors are instructed to consult the Regional Focal Points in an informal
manner.
The Regional Focal Points will be invited to participate the board of reviewers.
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
9
7. BMCDDA proposition: collaborative organisation of national REITOX academy in
2012
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
10
8. BMCDDA position: financing of toxicological analyses
8.1. RAPID: Risico Analyse Project voor het Identificeren van Drugstalen
Initiative: VAD
Method: testing of substances provided by users with negative experience
Setting: RIZIV centres
WIV-ISP: Asked to finance analyses for €20.000. Negative advise
8.2. TESTING: Projet d’Analyse de Substances Psychotropes
Initiative: Modus Vivendi
Method: testing of substances provided by users asking for feedback
Setting: Party scene + fixed points
WIV-ISP: Asked to finance analyses for €200 per analysis (real cost = 260; contribution of MV: €60). Negative advise
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
11
9. Varia
Wetenschap ten dienste van Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu.
12